WHO Drug Information Vol. 13, No. 4, 1999
(1999; 83 pages) View the PDF document
Table of Contents
Close this folderGeneral Policy Issues
View the documentAccess to essential drugs
View the documentWHO's role in ensuring access to essential drugs
View the documentAccess to medicines: an urgent need for solutions
View the documentAmsterdam statement on access to medicines*
Open this folder and view contentsReports on Individual Drugs
Open this folder and view contentsCurrent Topics
Open this folder and view contentsVaccines and Biomedicines
Open this folder and view contentsRegulatory and Safety Matters
Open this folder and view contentsATC/DDD Classification
Open this folder and view contentsEssential Drugs
View the documentInternational Nonproprietary Names for Pharmaceutical Substances (INN)
View the documentSelected WHO Publications of Related Interest
 

Access to essential drugs

A conference on Increasing Access to Essential Drugs in a Globalized Economy: Working Towards Solutions was organized by Médecins Sans Frontières, Health Action International, and Consumer Project on Technology in Amsterdam, the Netherlands, on November 25-26, 1999.

Access to essential drugs is of importance to the World Health Organization whose longstanding aim is to ensure equity of access and rational use of essential drugs of quality. This underpins the fundamental right to health care by all people. WHO has made tangible progress towards securing this right but there is still a long way to go. As a result of the conference, a statement was prepared for presentation to the World Trade Organization (WTO) during their subsequent conference in Seattle calling on Member States to consider the needs of developing countries by strengthening TRIPS provisions with regard to public health priorities.

to previous section to next section
 

Last updated: May 3, 2013